Cardiac complications attributed to chloroquine and hydroxychloroquine: a systematic review of the literature

C Chatre, F Roubille, H Vernhet, C Jorgensen, YM Pers - Drug safety, 2018 - Springer
Introduction Chloroquine and hydroxychloroquine are widely used in the long-term treatment
of connective tissue disease and usually considered safe. However, chloroquine- or …

Deregulation and therapeutic potential of microRNAs in arthritic diseases

R Vicente, D Noël, YM Pers, F Apparailly… - Nature Reviews …, 2016 - nature.com
Epigenetic abnormalities are part of the pathogenetic alterations involved in the development
of rheumatic disorders. In this context, the main musculoskeletal cell lineages, which are …

Adipose mesenchymal stromal cell-based therapy for severe osteoarthritis of the knee: a phase I dose-escalation trial

YM Pers, L Rackwitz, R Ferreira, O Pullig… - Stem cells …, 2016 - academic.oup.com
Although this phase I study included a limited number of patients without a placebo arm, it
showed that local injection of autologous adipose-derived stem cells was safe and well …

[HTML][HTML] The challenges of telemedicine in rheumatology

…, L Bernard, C Jorgensen, G Dusfour, YM Pers - Frontiers in …, 2021 - frontiersin.org
During the past 20 years, the development of telemedicine has accelerated due to the rapid
advancement and implementation of more sophisticated connected technologies. In …

[HTML][HTML] p16INK4a and its regulator miR-24 link senescence and chondrocyte terminal differentiation-associated matrix remodeling in osteoarthritis

…, E Olivotto, F Espinoza, A Dorandeu, YM Pers… - Arthritis research & …, 2014 - Springer
Introduction Recent evidence suggests that tissue accumulation of senescent p16 INK4a -positive
cells during the life span would be deleterious for tissue functions and could be the …

Non–TNF-targeted biologic vs a second anti-TNF drug to treat rheumatoid arthritis in patients with insufficient response to a first anti-TNF drug: a randomized clinical …

…, I Chary-Valckenaere, O Vittecoq, A Saraux, YM Pers… - Jama, 2016 - jamanetwork.com
Importance One-third of patients with rheumatoid arthritis show inadequate response to tumor
necrosis factor α (TNF-α) inhibitors; little guidance on choosing the next treatment exists. …

Predictors of response and remission in a large cohort of rheumatoid arthritis patients treated with tocilizumab in clinical practice

YM Pers, C Fortunet, E Constant, J Lambert… - …, 2014 - academic.oup.com
Objective. The objective of this study was to identify predictors of response and remission to
tocilizumab (TCZ) in RA patients seen in daily routine clinical practice. Methods. The efficacy …

[HTML][HTML] Multidisciplinary assessment of post-Ebola sequelae in Guinea (Postebogui): an observational cohort study

…, H Niane, M Peeters, YM Pers… - The Lancet Infectious …, 2017 - thelancet.com
Background The high number of survivors from the 2013–16 west African outbreak of Ebola
virus disease (EVD) has raised several new issues: long-term clinical complications, …

[HTML][HTML] Circulating miRNA-125b is a potential biomarker predicting response to rituximab in rheumatoid arthritis

I Duroux-Richard, YM Pers, S Fabre… - Mediators of …, 2014 - hindawi.com
Although biologic therapies have changed the course of rheumatoid arthritis (RA), today’s
major challenge remains to identify biomarkers to target treatments to selected patient groups. …

Efficacy of tocilizumab in patients with hand osteoarthritis: double blind, randomised, placebo-controlled, multicentre trial

…, D Wendling, M Piperno, P Goupille, YM Pers… - Annals of the …, 2021 - ard.bmj.com
Objective To evaluate the efficacy of tocilizumab, an antibody against IL-6 receptor, in patients
with hand osteoarthritis. Methods This was a multicentre, 12-week, randomised, double-…